Extracted from this filing and checked against the source text.
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
Evolve Transition Infrastructure LP received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii)).
- Exchange
- nyse american
- Notice
- deficiency notice
- Deficiency
- stockholders equity
- Rules
- 1003(a)(i), 1003(a)(ii)
Exact text from the filing
ate the status of the Common Units as “below compliance.” The “.BC” designation was first added following Evolve’s receipt of notice (the “ 12.6.22 Notice ”) from the NYSE American that Evolve was below compliance with certain of the NYSE American’s continued listing standards set forth in Sections 1003(a)(i) and 1003(a)(ii) of the Company Guide. The 12.6.22 Notice and the 12.27.22 Notice do not result in the immediate delisting of the Common Units from the NYSE American. Pursuant to Section 1003(f)(v) of the Company Guide, the NYSE American staff determined that Evolve’s continued listing is
View on SEC.gov
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
Evolve Transition Infrastructure LP received a nyse_american deficiency notice notice regarding minimum bid price (rules 1003(f)(v)).
- Exchange
- nyse american
- Notice
- deficiency notice
- Deficiency
- minimum bid price
- Rules
- 1003(f)(v)
Exact text from the filing
December 27, 2022, Evolve received notice (the “ 12.27.22 Notice ”) from NYSE American LLC (“ NYSE American ”) that Evolve was not in compliance with the continued listing standards set forth in Section 1003(f)(v) of the NYSE American Company Guide (the “ Company Guide ”) because its Common Units have been selling for a substantial period of time at a low price per Common Unit, which NYSE American has determined to be a 30-trading-day average price of less than $0.20 per Common Unit. The 12.27.22 Notice has no immediate effect on the listing or trading of Evolve’s Common Units and the Common U
View on SEC.gov